tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ABOS Stock Latest News

Acumen price target lowered to $8 from $9 at BofA
The FlyAcumen price target lowered to $8 from $9 at BofA
7d ago
ABOS
Acumen first participant dosed in OLE portion of Phase 2 ALTITUDE-AD trial
PremiumThe Fly
Acumen first participant dosed in OLE portion of Phase 2 ALTITUDE-AD trial
9d ago
ABOS
Acumen Pharmaceuticals Reports Q3 2025 Financial Results
PremiumCompany Announcements
Acumen Pharmaceuticals Reports Q3 2025 Financial Results
13d ago
ABOS
Acumen Pharmaceuticals’ Earnings Call: Progress and Challenges
PremiumCompany Announcements
Acumen Pharmaceuticals’ Earnings Call: Progress and Challenges
13d ago
ABOS
Acumen Pharmaceuticals Reports Q3 Financial Results
PremiumCompany Announcements
Acumen Pharmaceuticals Reports Q3 Financial Results
14d ago
8K
ABOS
Acumen reports Q3 EPS (44c), consensus (68c)
PremiumThe FlyAcumen reports Q3 EPS (44c), consensus (68c)
14d ago
ABOS
Acumen sees cash runway into early 2027
Premium
The Fly
Acumen sees cash runway into early 2027
14d ago
ABOS
Acumen Pharmaceuticals Appoints New Board Chairman
Premium
Company Announcements
Acumen Pharmaceuticals Appoints New Board Chairman
16d ago
8K
ABOS
Acumen appoints George Golumbeski as chairman of the board
PremiumThe Fly
Acumen appoints George Golumbeski as chairman of the board
16d ago
ABOS
ABOS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ABOS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
16d ago
ABOS
Acumen price target lowered to $4 from $11 at BTIG
PremiumThe Fly
Acumen price target lowered to $4 from $11 at BTIG
1M ago
ABOS
Acumen Pharmaceuticals’ Earnings Call Highlights Strategic Growth
PremiumCompany Announcements
Acumen Pharmaceuticals’ Earnings Call Highlights Strategic Growth
3M ago
ABOS
Acumen price target lowered to $9 from $10 at BofA
PremiumThe FlyAcumen price target lowered to $9 from $10 at BofA
3M ago
ABOS
Acumen Pharmaceuticals’ Q2 2025 Financial and Strategic Update
Premium
Company Announcements
Acumen Pharmaceuticals’ Q2 2025 Financial and Strategic Update
3M ago
ABOS
Acumen Pharmaceuticals Reports Q2 Financial Results and Innovations
Premium
Company Announcements
Acumen Pharmaceuticals Reports Q2 Financial Results and Innovations
4M ago
8K
ABOS
Acumen reports Q2 EPS (68c), consensus (52c)
PremiumThe Fly
Acumen reports Q2 EPS (68c), consensus (52c)
4M ago
ABOS
Acumen sees cash runway into early 2027
PremiumThe Fly
Acumen sees cash runway into early 2027
4M ago
ABOS
ABOS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ABOS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
ABOS
Acumen Pharmaceuticals’ Promising Alzheimer’s Study: A Potential Game-Changer?
PremiumCompany Announcements
Acumen Pharmaceuticals’ Promising Alzheimer’s Study: A Potential Game-Changer?
4M ago
ABOS
Acumen presents results from its Phase 2 ALTITUDE-AD study of sabirnetug
PremiumThe FlyAcumen presents results from its Phase 2 ALTITUDE-AD study of sabirnetug
4M ago
ABOS
Strategic Buy Rating for Acumen Pharmaceuticals: Leveraging JCR Collaboration to Enhance Asset Delivery and Differentiation
Premium
Ratings
Strategic Buy Rating for Acumen Pharmaceuticals: Leveraging JCR Collaboration to Enhance Asset Delivery and Differentiation
4M ago
ABOS
Acumen Pharmaceuticals Partners with JCR for Alzheimer’s Treatment
Premium
Company Announcements
Acumen Pharmaceuticals Partners with JCR for Alzheimer’s Treatment
4M ago
8K
ABOS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >